Items where Author is "Di Biase, A"

Journal article

FERRI, C., DI BIASE, A., BOCCHETTI, M., ZAPPAVIGNA, S., WAGNER, S., LE VU, P., LUCE, A., COSSU, A.M., VADAKEKOLATHU, J., MILES, A., BOOCOCK, D.J., ROBINSON, A., SCHWERDTFEGER, M., TIRINO, V., PAPACCIO, F., CARAGLIA, M., REGAD, T. and DESIDERIO, V., 2022. MiR-423-5p prevents MALAT1-mediated proliferation and metastasis in prostate cancer. Journal of Experimental and Clinical Cancer Research, 41 (1): 40. ISSN 1756-9966

BARBATO, L., BOCCHETTI, M., DI BIASE, A. and REGAD, T., 2019. Cancer stem cells and targeting strategies. Cells, 8 (8), p. 926. ISSN 2073-4409

VADAKEKOLATHU, J., AL-JUBOORI, S.I.K., JOHNSON, C., SCHNEIDER, A., BUCZEK, M.E., DI BIASE, A., POCKLEY, A.G., BALL, G.R., POWE, D.G. and REGAD, T., 2018. MTSS1 and SCAMP1 cooperate to prevent invasion in breast cancer. Cell Death & Disease, 9: 344. ISSN 2041-4889

Chapter in book

DI BIASE, A., MILES, A.K. and REGAD, T., 2018. Generation of in vitro model of epithelial mesenchymal transition (EMT) via the expression of a cytoplasmic mutant form of promylocytic leukemia protein (PML). In: G. PAPACCIO and V. DESIDERIO, eds., Cancer stem cells. Methods in molecular biology (1692). New York: Humana Press, pp. 129-138. ISBN 9781493974009

Thesis

DI BIASE, A., 2020. Generation of α-EPCR monoclonal antibodies and their use in the development of an antibody-based targeting therapy of invasive prostate cancer. PhD, Nottingham Trent University.